Ontology highlight
ABSTRACT: Background
Multiple studies have shown that amiodarone is effective in treating atrial fibrillation (AF), but is associated with a relatively high incidence of side effects; however, due to amiodarone's long elimination half-life (20-100 days), physicians may hesitate to start other drugs until it has fully cleared.Hypothesis
A rapid switch from amiodarone to dronedarone is feasible.Methods
EURIDIS and ADONIS were double-blind, multinational, parallel-group trials comparing the efficacy and safety of dronedarone with placebo over 12 months. This retrospective subanalysis of EURIDIS/ADONIS compared the effects of dronedarone in patients discontinuing amiodarone within 2 days before randomization ("rapid switch") with results in patients who had received no amiodarone
SUBMITTER: Immordino L
PROVIDER: S-EPMC6649410 | biostudies-literature | 2013 Feb
REPOSITORIES: biostudies-literature